UNICA IRIS Institutional Research Information System

KOWALIK, MARTA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 93.286
NA - Nord America 3.364
AS - Asia 1.383
SA - Sud America 191
AF - Africa 47
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 98.276
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 92.334
US - Stati Uniti d'America 3.299
SG - Singapore 520
CN - Cina 509
SE - Svezia 275
DE - Germania 170
BR - Brasile 161
UA - Ucraina 145
VN - Vietnam 114
GB - Regno Unito 106
FI - Finlandia 60
CA - Canada 47
FR - Francia 39
KR - Corea 37
TR - Turchia 33
IN - India 27
PL - Polonia 24
ZA - Sudafrica 22
HK - Hong Kong 21
BE - Belgio 20
IR - Iran 18
NL - Olanda 18
JP - Giappone 17
BD - Bangladesh 16
MA - Marocco 15
MX - Messico 15
RU - Federazione Russa 14
AT - Austria 13
ES - Italia 13
AR - Argentina 9
IE - Irlanda 9
IQ - Iraq 9
LT - Lituania 7
MY - Malesia 7
CH - Svizzera 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
DK - Danimarca 5
EC - Ecuador 5
IL - Israele 5
JO - Giordania 5
MT - Malta 5
SA - Arabia Saudita 5
TW - Taiwan 5
PT - Portogallo 4
AU - Australia 3
EG - Egitto 3
HU - Ungheria 3
ID - Indonesia 3
KE - Kenya 3
KZ - Kazakistan 3
LK - Sri Lanka 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
NO - Norvegia 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 98.276
Salva come PNG Salva come JPEG
Città #
Cagliari 90.484
Uta 1.594
Ashburn 388
Fairfield 328
Singapore 263
Woodbridge 216
Chandler 202
Nyköping 180
Houston 160
Ann Arbor 150
Boardman 144
Beijing 125
Los Angeles 125
Seattle 121
Wilmington 115
Dallas 111
Cambridge 105
Dearborn 82
Jacksonville 65
Santa Clara 54
New York 53
Hefei 42
The Dalles 41
Shanghai 39
Nanjing 31
Seoul 31
Dong Ket 28
Munich 25
Helsinki 24
Ho Chi Minh City 23
London 23
Redwood City 23
Warsaw 22
Boston 21
Buffalo 21
Hong Kong 21
Brussels 20
Hanoi 20
Toronto 20
Kocaeli 19
San Mateo 19
Milan 18
Rome 18
São Paulo 18
Frankfurt am Main 17
Guangzhou 17
Stockholm 17
Chicago 16
Redondo Beach 16
Montreal 15
San Diego 15
Denver 14
Johannesburg 14
Casablanca 12
Falls Church 12
Turku 12
Atlanta 11
Chennai 11
Jiaxing 11
Mountain View 11
Nuremberg 11
Phoenix 11
Brooklyn 10
Nanchang 10
Amsterdam 9
Bari 9
Pisa 9
Tokyo 9
Council Bluffs 8
Dublin 8
Rio de Janeiro 8
Shenyang 8
Shenzhen 8
Vienna 8
Augusta 7
Bogazici 7
Changsha 7
Columbus 7
Düsseldorf 7
Florence 7
Haiphong 7
Leawood 7
Norwalk 7
Poplar 7
Pune 7
Tianjin 7
Auburn Hills 6
Da Nang 6
Ferrara 6
Manchester 6
Milwaukee 6
Orange 6
Regensburg 6
Amman 5
Ankara 5
Ardabil 5
Biên Hòa 5
Curitiba 5
Lauterbourg 5
Millbury 5
Totale 96.140
Salva come PNG Salva come JPEG
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 5.964
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.934
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.216
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.197
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.985
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.915
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.821
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.699
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.667
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.614
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.549
Global gene expression profile of normal and regenerating liver in young and old mice 3.522
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.426
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.127
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.113
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.025
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.734
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.609
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.338
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP 2.319
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.291
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.093
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.968
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.612
Early metabolic changes in a liver carcinogenesis model 1.468
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.416
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.400
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.178
Early Metabolic Changes in preneoplastc nodules of the liver 1.138
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 913
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 909
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 852
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 827
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 810
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 785
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 779
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 700
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 644
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 640
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 569
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 478
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 461
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 423
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 409
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 402
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 382
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 379
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 305
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 278
Galectin-3 inhibition ameliorates hepatic steatosis in a multilineage 3D spheroid model 81
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 77
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 28
Totale 98.469
Salva come PNG Salva come JPEG
Categoria #
all - tutte 118.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.094 0 0 0 0 0 2.054 1.286 1.207 610 1.157 1.171 609
2021/20225.325 767 352 233 343 519 371 210 192 545 575 609 609
2022/20237.951 462 877 1.022 712 636 885 514 464 527 651 792 409
2023/20247.638 475 253 275 387 737 1.172 1.336 688 354 446 638 877
2024/202521.115 7.396 7.556 1.492 1.484 689 893 981 78 128 125 130 163
2025/20262.006 349 205 343 374 451 284 0 0 0 0 0 0
Totale 98.469